News & Analysis on Clinical Trial Services & Contract Research And Development
It is no secret that India is becoming a major force in the world market for active pharmaceutical ingredients, but recent developments suggest that companies in the country may be gearing up to play a similar role in inactive ingredients.
Solvay has doubled the output of hydrogen peroxide (H2O2) at its Solvay Interox industrial pilot plant in Povoa, Portugal, using a new high-yield process.
LION bioscience has delayed the publication of its third-quarter results after a change in its accounting procedures that will see licence revenues spread across the term of the contracts, instead of booked in the quarter they are signed.
GlaxoSmithKline is collaborating with an Israeli firm on a new technology that could provide a painless means of delivering vaccines into the skin.